Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers:
4.1.1.1. The growing demand of gene therapy and immunotherapy
4.1.1.2. Increase in the incidence of diseases such as cancer and genetic disorders.
4.1.2. Restraints:
4.1.2.1. Risk of mutagenesis
4.1.2.2. High cost of gene therapy
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Regulatory Analysis
5.3. Supply Chain Analysis
5.4. Pricing Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
6.7. Others
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
7.1.2. Market Attractiveness Index, By Product Type Segment
7.2. Plasmid DNA
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Viral Vector
7.3.1. Retroviral Vectors
7.3.2. Adenoviral Vectors
7.3.3. Lentiviral Vectors
7.3.4. Adeno-Associated Viral Vectors
7.3.5. Others
7.4. Non-Viral Vector
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Cancer
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Mn and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Genetic Disorder
8.4. Infectious Disease
8.5. Other Diseases
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.2.5.1. U.S.
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.3.5.1. Germany
9.3.5.2. U.K.
9.3.5.3. France
9.3.5.4. Italy
9.3.5.5. Spain
9.3.5.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.4.5.1. Brazil
9.4.5.2. Argentina
9.4.5.3. Rest of South America
9.5. Asia Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.5.5.1. China
9.5.5.2. India
9.5.5.3. Japan
9.5.5.4. Australia
9.5.5.5. Rest of Asia Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10. Competitive Landscape
10.1. Key Developments and Strategies
10.2. Company Share Analysis
10.3. Product Type Benchmarking
10.4. List of Key Companies to Watch
11. Company Profiles
11.1. Brammer Bio (Thermo Fisher Scientific Inc.)
11.1.1. Company Overview
11.1.2. Product Type Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. Cobra Biologics
11.3. Cell and Gene Therapy Catapult
11.4. FinVector Vision Therapies
11.5. Fujifilm Diosynth Biotechnologies
11.6. MassBiologics
11.7. SIRION Biotech
11.8. Merck KGaA Inc.
11.9. Thermo Fisher Scientific
11.10. Uniqure NV
LIST NOT EXHAUSTIVE
12. Global Viral Vector and Plasmid DNA Manufacturing Market – DataM
12.1. Appendix
12.2. About Us and Usability
12.3. Contact Us